Cellular therapies have transformed the treatment landscape for hematologic malignancies.Growing evidence suggests they soon may have a similarly profound impact on autoimmune and other immunological disorders.
Column
Blog: ASTCT Update
September 08, 2026
5 min read
Add topic to email alerts
Patients with systemic lupus erythematosus who received autologous chimeric antigen receptor T-cell therapy enjoyed potent B-cell…
Find the latest Cell Therapy news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders…
It’s a crucial moment for the cell and gene therapy field. At the American Society of Gene & Cell Therapy’s annual meeting,…
VIDEO: Immunotherapies offer new opportunities in relapsed, refractory myeloma
A dual-target CD19/BCMA chimeric antigen receptor T-cell therapy yielded “profound, sustained” remission in 11 patients with…
Explore the potential of CAR-T therapy as a groundbreaking treatment for autoimmune diseases, offering long-term remission…
